ImmuPharma's market cap is currently £55.80M. The company's EPS TTM is p-0.004; its P/E ratio is ―; ImmuPharma is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
